Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Total Debt: 2009-2024

Historic Total Debt for Prestige Consumer Healthcare (PBH) over the last 11 years, with Mar 2024 value amounting to $1.1 billion.

  • Prestige Consumer Healthcare's Total Debt fell 16.35% to $1.1 billion in Q1 2024 from the same period last year, while for Mar 2024 it was $1.1 billion, marking a year-over-year decrease of 16.35%. This contributed to the annual value of $1.1 billion for FY2024, which is 16.35% down from last year.
  • Prestige Consumer Healthcare's Total Debt amounted to $1.1 billion in Q1 2024, which was down 16.35% from $1.3 billion recorded in Q1 2023.
  • In the past 5 years, Prestige Consumer Healthcare's Total Debt ranged from a high of $1.7 billion in Q1 2020 and a low of $6.0 million during Q3 2021.
  • Over the past 3 years, Prestige Consumer Healthcare's median Total Debt value was $1.3 billion (recorded in 2023), while the average stood at $1.3 billion.
  • Data for Prestige Consumer Healthcare's Total Debt shows a maximum YoY tumbled of 99.61% (in 2021) over the last 5 years.
  • Prestige Consumer Healthcare's Total Debt (Quarterly) stood at $1.5 billion in 2020, then slumped by 99.61% to $6.0 million in 2021, then dropped by 0.20% to $1.5 billion in 2022, then fell by 8.86% to $1.3 billion in 2023, then declined by 16.35% to $1.1 billion in 2024.
  • Its Total Debt was $1.1 billion in Q1 2024, compared to $1.3 billion in Q1 2023 and $1.5 billion in Q1 2022.